A User’s Guide to Cancer-Related News


By Vish Viswanath, PhD


News about advances in cancer research and treatment appears almost daily. The pace at which new findings are reported, coupled with the complexity of the underlying science, can make it difficult to know which studies are truly significant and which are less so. It’s easy to become confused when reports seem to have varying conclusions.

Here are some tips for becoming a savvy consumer of cancer news.

  • News coverage of cancer tends to be episodic: each new study is presented in a separate newspaper, TV story, or online channel. This can obscure the fact that science is a process, and new studies are only the latest chapter in a course of discovery. As a result, the findings of a single study are not always sufficient to change the way cancer medicine is practiced. It’s important to ask whether a study is the first to make a particular finding, or whether it is confirming previous research. In general, an important finding must be reproduced by other researchers before it affects patient care.
  • SOG_2113_12Look for information about who is funding a particular study. A drug manufacturer that funds a study of one of its own products clearly has an inherent interest in the outcome. This isn’t by any means to say that studies funded by private industry always produce questionable results, but it’s worth keeping the funder’s connection to the study in mind.
  • If the report concerns a clinical research study, pay attention to how many patients were involved. In general, the more patients and the greater variety of patients who participated, the more broadly applicable the findings are.
  • If the study involves a clinical trial in which a new therapy is tested with patients, note which phase of research the trial involved. Phase 1 studies, for example, generally involve a small number of patients and are conducted primarily to see whether a potential treatment is safe and what doses are appropriate. Phase 3 trials, by contrast, involve treatments that are closer to becoming approved.

In his lab, Dr. Viswanath studies the role of communication in health promotion, with a focus on communication inequities and health disparities.

Comments Sort By Newest

Leave a Reply

Your email address will not be published. Required fields are marked *

Blue Captcha Image


Make An Appointment

For adults: 877-442-3324

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
@randysusanmeyer that was not our intention. https://t.co/viZJ11Imhl
Dana-Farber @danafarber
Thank you @Marketeer2u. Yes, that was not our intention. https://t.co/uyHo9Sej1W
Dana-Farber @danafarber
@singaporestacey That was not our intention. https://t.co/WZ7XCHuWKh

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.